BeiGene’s hematology CMO jumps to steer pipeline changes at Preludenews2022-03-09T14:04:25+00:00March 9th, 2022|FierceBiotech|
J&J’s long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pactnews2022-03-09T13:46:36+00:00March 9th, 2022|FierceBiotech|
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulatorsnews2022-03-09T10:10:49+00:00March 9th, 2022|FierceBiotech|
BioNTech-Regeneron add 3rd tumor type to partnership testing cancer vaccines with Libtayonews2022-03-08T15:37:56+00:00March 8th, 2022|FierceBiotech|
Sanofi deploying $1B to turn France into ‘pioneer mRNA nation’news2022-03-08T14:53:31+00:00March 8th, 2022|FierceBiotech|
Creyon joins wave of AI biotechs with $40M to create ‘on demand’ RNA-based medicinesnews2022-03-08T13:59:31+00:00March 8th, 2022|FierceBiotech|
Valneva heads to FDA as durability of chikungunya vaccine holds up in phase 3 news2022-03-08T13:11:24+00:00March 8th, 2022|FierceBiotech|
Late-stage biotechs, Kurma has €160M to help you clear the final hurdles in the race to marketnews2022-03-08T10:45:35+00:00March 8th, 2022|FierceBiotech|
Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pactnews2022-03-07T21:53:54+00:00March 7th, 2022|FierceBiotech|
J&J to celebrate Carvykti nod without Janssen oncology chief as Serge Messerlian nabs Teon CEO jobnews2022-03-07T18:40:08+00:00March 7th, 2022|FierceBiotech|
